Regulatory & Reimbursement
Pathways' Pick of the Week: Modernizing Inspections
FDA lays out a new vision for inspections. Excerpted from Pathways Picks August 5: Medicare Tightens NTAP Access, MDUFA Money, UK on AI Scribes, and More.
Welcome to MyStrategist.
MedTech Strategist's complimentary Community Blog focuses on the people and the passions that drive the global medical device industry. Sign up for our e-Newsletter to receive new articles and video interviews directly to your inbox.
e-Newsletter BrowseStart a free trial and unlock 5-days of exclusive subscriber-only access to MedTech Strategist & Market Pathways
Start Trial
ICYMI
The End of Watchful Waiting for AAAs
New device-based interventions for AAA may offer an alternative to prolonged surveillance in treating abdominal aortic aneurysms. Excerpted from our recent MTS feature, "Living Under Surveillance: Can New AAA Treatments Change the Story?"
Discover the opportunities and challenges that impact the global medtech regulatory and reimbursement community with Market Pathways.
Subscribe Free Premier Issue Learn More
Regulatory & Reimbursement
Pathways' Pick of the Week: FDA Consolidates Operations
The agency outlines new centralized operations. Excerpted from Pathways Picks July 29: FDA Consolidation, User Fees Rise, South Korea Streamlines .
Discover the people, technologies, and companies in the global medical device industry that will impact your corporate strategy with MedTech Strategist.
Subscribe Now Learn More
ICYMI
The End of Watchful Waiting for AAAs
New device-based interventions for AAA may offer an alternative to prolonged surveillance in treating abdominal aortic aneurysms. Excerpted from our recent MTS feature, "Living Under Surveillance: Can New AAA Treatments Change the Story?"